Hughes A, Sever P
Department of Clinical Pharmacology, St Mary's Hospital Medical School, London, U.K.
Biochem Pharmacol. 1989 Mar 1;38(5):781-5. doi: 10.1016/0006-2952(89)90231-1.
Binding of the selective D-1 dopamine receptor ligand 125I SCH 23982 was studied using crude plasma membranes derived from human renal cortex. 125I SCH 23982 bound saturably to a single high affinity site (Kd = 650 pM, Bmax = 19 fmol/mg protein). Binding at 37 degrees was rapid and reversible with forward and reverse rate constants of 5.79 x 10(8) min-1 m-1 and 0.156 min-1 respectively. Antagonist and agonist competition for 125I SCH 23982 binding was also consistent with the existence of a single site possessing pharmacological characteristics similar to a D-1 dopamine receptor. It is suggested that this site may represent a D-1 (or DA1) dopamine receptor present in human renal cortex.
利用源自人肾皮质的粗制质膜研究了选择性D-1多巴胺受体配体125I SCH 23982的结合情况。125I SCH 23982可饱和地结合至单一高亲和力位点(解离常数Kd = 650皮摩尔,最大结合容量Bmax = 19飞摩尔/毫克蛋白质)。37摄氏度时的结合迅速且可逆,正向和逆向速率常数分别为5.79×10(8) 分钟-1 米-1 和0.156分钟-1。拮抗剂和激动剂对125I SCH 23982结合的竞争也与存在一个具有类似于D-1多巴胺受体药理学特征的单一位点相一致。提示该位点可能代表存在于人肾皮质中的D-1(或DA1)多巴胺受体。